Mycobacterium tuberculosis rifampin-resistance mutation visual detection probes and application thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- WUHAN UNIV
- Publication Date
- 2012-08-08
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the fields of pathogenic biology, molecular microbiology and nucleic acid chemistry, and relates to a design method and sequence of a novel gene point mutation detection probe, and its application in the detection of rifampicin-resistant mutations of Mycobacterium tuberculosis. This method can intuitively, rapidly and visually detect rifampicin-resistant mutations in Mycobacterium tuberculosis. Background technique
[0002] Tuberculosis (TB for short) caused by Mycobacterium tuberculosis is an ancient disease that has been widely spread in the world long ago. Since the 1950s, effective drugs such as isoniazid and rifampicin have been discovered for the treatment of tuberculosis. , greatly improved the cure rate of tuberculosis, and reduced the recurrence rate of tuberculosis, making tuberculosis a curable and controllable disease. In some developed countries, tuberculosis has been largely brought under control. However, in re...